Position in AZN
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$14,909,062
+$707,645 QoQ
Shares Held
78,626
+9.2% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
#262
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HUB Investment Partners, LLC holds $120,989,044 across 14 Drug Manufacturers - General names. AZN ranks #4 (12.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
158,806 | $39,961,941 | |
| 2 | JNJ |
Johnson & Johnson
|
72,119 | $18,316,062 | |
| 3 | LLY |
ELI LILLY & Co
|
14,924 | $17,900,294 | |
| 4 | AZN |
Astrazeneca PLC
This page
|
78,626 | $14,909,062 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
87,005 | $10,992,211 | |
| 6 | MRK |
Merck & Co., Inc.
|
51,940 | $6,674,290 | |
| 7 | PFE |
Pfizer Inc
|
197,054 | $4,745,060 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
39,485 | $2,275,125 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,909,062 | 78,626 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $14,201,417 | 72,008 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||